NUWE
Nuwellis Inc
NASDAQ: NUWE · HEALTHCARE · MEDICAL DEVICES
$1.11
+0.00% today
Updated 2026-04-29
Market cap
$3.06M
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-25.39
Dividend yield
—
52W range
$1 – $45
Volume
0.1M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$11.00
+890.99%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at -211.90%
- Negative free cash flow $-3.04M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $8.54M | $8.86M | $8.74M | $8.27M | $8.27M |
| Net income | $-14.53M | $-20.21M | $-11.16M | $-17.52M | $-2.42M |
| EPS | — | — | — | — | $-25.39 |
| Free cash flow | $-15.27M | $-18.18M | $-9.65M | $-10.90M | $-3.04M |
| Profit margin | -170.02% | -227.99% | -127.75% | -211.81% | -211.90% |
Peer comparison
Smart narrative
Nuwellis Inc trades at $1.11. Our Smart Value Score of 28/100 indicates the stock is weak. TTM revenue stands at $8.27M. with profit margins at -211.90%.
Frequently asked questions
What is Nuwellis Inc's stock price?
Nuwellis Inc (NUWE) trades at $1.11.
Is Nuwellis Inc overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell).
What is the price target of Nuwellis Inc (NUWE)?
The analyst target price is $11.00, representing +891.0% upside from the current price of $1.11.
What is Nuwellis Inc's revenue?
TTM revenue is $8.27M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.37x
ROE-382.50%
Beta0.08
50D MA$1.30
200D MA$3.48
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—